About Iovance (IOVA)
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own imm... Read more
- USD11.50
- USD11.65
- USD11.16
- USD18.33
- -20.60%
- 1M
- 2.25k
- 4.26M
- 3.2B
- 3.21
- 109.40%
Stock News
4 hours ago
1 Magnificent S&P 500 Dividend Stock Down 20% to Buy and Hold Forever
Yahoo
5 hours ago
Third Coast Bancshares Inc (TCBX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Yahoo
5 hours ago
Why Are Shares of Intel Stock Crashing After Earnings?
Yahoo
6 hours ago
Anglo Rejects BHP Takeover Proposal as Significantly Undervalued
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
